- Independent Ophthalmology Reading Center for Clinical Trials
- Established partner of choice for past and ongoing pivotal studies with global market leaders, biotech companies,
and academic partners in retina and neurology - End-to-end expertise supporting Phase I–IV clinical trials
- Strategic consulting to optimize imaging parameters and clinical readouts
- Founded and led by internationally recognized retina specialists with extensive global networks and hundreds of peer-reviewed publications in retinal therapy and imaging
- Dedicated professional team of approximately 16 experts, including specialised IT staff and experienced project managers
- Highly qualified graders, primarily trained physicians and ophthalmologists with advanced specialization in retinal imaging
- Industry-leading quality standards, including independent double grading to ensure data reliability and consistency
- Retinal endpoint adjudication
- More than 10 year history of development of AI tools
- Strong expertise in imaging biomarker development
- Quality assurance workflows
- Secure, proprietary data platform fully compliant with GDPR requirements
We provide high-standard image reading services that combine advanced imaging technology with the expertise of experienced retinal specialists. Our center delivers precise, reliable, and consistent ophthalmic image analysis to support clinical research and patient care. With a strong commitment to quality and innovation, we partner with you to achieve the highest standards in retinal health, helping drive better outcomes through trusted scientific excellence.